In-Vitro Research Services
Scoped In-Vitro Research Support in Hyderabad
Manna Biotech supports feasible research-use in-vitro work through current cell-culture, microbiology, molecular-biology and bioinformatics capability. Every enquiry is reviewed for the biological model, endpoint, controls, sample requirements, biosafety, intended use and reporting needs before a method or timeline is confirmed.
Current research scope
Focused in-vitro work with method, model and intended-use boundaries stated upfront.
Cell-culture research support
Current mammalian cell-culture maintenance, supervised training and basic project-specific research support, subject to cell line, biosafety and assay feasibility.
Microbiology and antimicrobial screening
Research-use culture, microbial screening and documented endpoint planning for suitable organisms and materials.
Molecular endpoints
PCR, qPCR, nucleic-acid isolation and related research endpoints where the sample matrix and method are feasible.
Experimental design
Controls, replicates, endpoint timing, data capture and interpretation planned around the scientific question.
Bioinformatics and statistics
Authorised-data analysis, figures and documented interpretation connected to the in-vitro study design.
Methods and raw outputs
Agreed methods documentation, raw or primary outputs and scoped scientific reporting without unsupported diagnostic or regulatory claims.
Scope Boundaries
Research-use service, not clinical diagnosis or an accredited statutory report.
Availability depends on model, method, biosafety, sample and endpoint feasibility. Advanced platforms are not presented as current Manna capability without documentary verification.
In-house now
Current basic cell-culture, microbiology, molecular-biology and related analysis capability within a confirmed project scope.
Requires separate verification
Flow cytometry/FACS, advanced organoids, complex bioanalysis, DMPK/ADME/PK-PD, toxicology, histology/IHC or accredited analytical work.
Outside this service
Animal-study execution, clinical diagnosis, patient treatment, deterministic disease prediction and unverified statutory claims.
Related services
Continue with the scientific support that fits your next step.
Cell-culture training
Use the learning route for supervised technique exposure and practical training.
PCR & qPCR testing
Scope focused research-use molecular endpoints and sample requirements.
Testing services
Review the broader research-use molecular, microbiology and authenticity testing menu.
CRO & contract research
Build a multi-stage commercial research programme under written milestones and IP terms.
Program options
Multiple tracks. One tailored plan for you.
Academic research module
A defined in-vitro component within an approved student, dissertation or PhD project.
Commercial feasibility study
A focused research-stage screen or proof-of-concept under written scope and NDA where appropriate.
Integrated molecular analysis
Connect a feasible in-vitro study to PCR/qPCR, sequencing, bioinformatics or statistical endpoints.
Fee Structure
Quoted only after model and endpoint feasibility.
Cost and turnaround depend on the biological model, controls, replicate plan, materials, assay endpoints, sample scale and reporting depth. We confirm current capability before issuing a written quote.
- Research question and model reviewed before acceptance
- Controls, replicates and outputs stated in the scope
- Advanced or regulated needs separated for verification
No result, publication, patent, regulatory approval or product performance is guaranteed. The client or scholar remains responsible for institutional and ethics approvals where applicable.
FAQ
Common questions.
Do you offer every type of in-vitro assay?+
No. We accept only work that fits current model, method, biosafety and equipment capability. Advanced assays are not offered as current services until the required facility or partner evidence is verified.
Is this clinical or diagnostic testing?+
No. This page covers research-use in-vitro support. It is not patient diagnosis, treatment, medical advice or a statutory testing service.
Can companies request an NDA?+
Yes. Send a non-confidential outline first; an NDA can be arranged before detailed commercial IP or formulation information is discussed.
Can this be integrated with bioinformatics or sequencing?+
Yes where scientifically appropriate. Molecular, sequencing and bioinformatics endpoints are scoped separately so inputs, quality checks, raw data and interpretation are clear.
Get started
Request an in-vitro research feasibility review.
Describe the model, sample, endpoint, intended use and timeline. We will confirm current capability, required inputs and any external-facility or compliance dependency before quotation.